-

Synthetic Biology Global Market Report 2022: Robotics and Workflow Automation Support Market Expansion - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Synthetic Biology - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Global Synthetic Biology Market to Reach $36 Billion by 2027

In the changed post COVID-19 business landscape, the global market for Synthetic Biology estimated at US$6.4 Billion in the year 2020, is projected to reach a revised size of US$36 Billion by 2027, growing at a CAGR of 28.1% over the analysis period 2020-2027. Oligonucleotides & Synthetic DNA, one of the segments analyzed in the report, is projected to record a 29.5% CAGR and reach US$16.1 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Enzymes segment is readjusted to a revised 27% CAGR for the next 7-year period.

The U.S. Market is Estimated at $2.5 Billion, While China is Forecast to Grow at 32.4% CAGR

The Synthetic Biology market in the U.S. is estimated at US$2.5 Billion in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$3.8 Billion by the year 2027 trailing a CAGR of 32.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 26.3% and 27.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 29.3% CAGR.

Cloning Technology Kits Segment to Record 26.8% CAGR

In the global Cloning Technology Kits segment, USA, Canada, Japan, China and Europe will drive the 26.8% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$939.9 Million in the year 2020 will reach a projected size of US$4.9 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets.

Select Competitors (Total 141 Featured) -

  • Agilent Technologies, Inc
  • Amyris, Inc
  • Arzeda
  • Atum
  • Codexis, Inc
  • Creative Enzymes
  • Cyrus Biotechnology, Inc
  • Editas Medicine, Inc
  • Eurofins Genomics Blue Heron LLC
  • Eurofins Scientific
  • GENEWIZ, Inc
  • GeneWorks Pty Ltd
  • Genscript Biotech Corporation
  • Ginkgo Bioworks
  • Integrated Dna Technologies, Inc
  • New England Biolabs
  • Novozymes A/S
  • OriGene Technologies, Inc
  • Sanofi S.A.
  • Synthego Corporation
  • TeselaGen Biotechnology Inc
  • Thermo Fisher Scientific, Inc
  • Twist Bioscience

What's New for 2022?

  • Global competitiveness and key competitor percentage market shares
  • Market presence across multiple geographies - Strong/Active/Niche/Trivial
  • Online interactive peer-to-peer collaborative bespoke updates
  • Access to a digital archives and Research Platform
  • Complimentary updates for one year

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

  • Synthetic Biology Market Witnesses Significant Rise in Investments
  • Importance of Synthetic Biology for Investments
  • Efforts from Leading Players Bodes Well for Market Growth
  • Patent Landscape Gets Richer
  • Robotics and Workflow Automation Support Market Expansion
  • Advancements in Instrumentation Augurs Well
  • Improvements in Computer-Aided Biology
  • Fusion of AI and Synthetic Biology Expands Opportunities
  • Synthetic Biology Brings a Paradigm Shift in the Field of Biological Research
  • DNA Sequencing Plays an Important Role
  • Plummeting Cost of DNA Sequencing Bolsters Market Growth
  • Food Scarcity to Fuel Synthetic Biology Application in Agriculture
  • Select Companies Engaged in Making Food Using Synthetic Biology
  • Synthetic Biology Aids in Development of Exotic and Artificially Grown Meats and Proteins to Meet Future Food Demand
  • Growing Demand for GM Crops Opens Up Growth Avenues
  • Synthetic Biology-based Ingredients Gain Traction
  • Role of Synthetic Biology in Producing Plants with Desirable Characteristics
  • Synthetic Biology Gains Prominence in Biomedical Applications
  • Synthetic Genes Open up a New World of Drug Development
  • Synthetic Biology to Transform Healthcare with Captivating Advances in Biomedicine
  • Synthetic Biology Enables Creation of Advanced Biosensing Systems
  • Synthetic Biology Gains Significance in Production of Bio-Based Chemicals and Biofuels
  • Synthetic Biology Gains Importance as Focus on Carbon Recycling Increases
  • Synthetic Biology Disrupts the Cosmetics Sector
  • Capability of Synthetic Biology in Environmental Applications
  • Synthetic Biology Creates Buzz as Key Enabler of Exciting & Dynamic Applications for Diverse Domains
  • Synthetic Biology for Advanced, Multifunctional Materials
  • Genetically Engineered Fabrics and Sustainable Dyes Using Synthetic Biology to Transform Textile Industry
  • Select Synthetic Biology Offerings in Textile Industry
  • Personalized Medicine to Display Notable Leap Forward with Synthetic Biology

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

REST OF WORLD

IV. COMPETITION

For more information about this report visit https://www.researchandmarkets.com/r/nwez5m

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

Protein Engineering for Pharmaceutical Biotechnology Training Course: Understand How to Advance Therapeutic Development and Industrial Applications (Jan 21st - Jan 22nd, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Protein Engineering for Pharmaceutical Biotechnology Training Course (Jan 21st - Jan 22nd, 2026)" training has been added to ResearchAndMarkets.com's offering. Enhance your knowledge in protein engineering to understand how to advance therapeutic development and industrial applications. Protein-based therapeutics have significantly advanced and created new paradigms in disease treatment. Half of the top ten selling drugs in 2023 were protein-based therapeutics. Pro...

Development of Combination Products: 2 Day Critical Interactions Training Course (Feb 9th - Feb 10th, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Development of Combination Products: Critical Interactions Training Course (Feb 9th - Feb 10th, 2026)" training has been added to ResearchAndMarkets.com's offering. The programme will cover the regulatory strategy to adopt and the relevant aspects of GMP and quality processes, including the data expectations for the CTD. It will also review the key relationships between quality, regulatory, R&D and production. Delegates will find this a comprehensive overview o...

Human Factors and Usability Engineering in the Development of Drug Delivery Products Training Course (Feb 11th - Feb 12th, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Human Factors and Usability Engineering in the Development of Drug Delivery Products Training Course (Feb 11th - Feb 12th, 2026)" training has been added to ResearchAndMarkets.com's offering. This two-day workshop has been designed specifically for product developers who want to incorporate human factors testing into their product development or need to provide the regulators with specific usability data for their device to comply with the MDR. The format for the d...
Back to Newsroom